Literature DB >> 24141097

Incidence and predictors of end-stage renal disease in outpatients with systolic heart failure.

Helle Bosselmann1, Gunnar Gislason, Finn Gustafsson, Per R Hildebrandt, Lars Videbaek, Lars Kober, Christian Torp-Pedersen, Niels Tonder, Kasper Rossing, Stefan Christensen, Anne-Lise Kamper, James Heaf, Morten Schou.   

Abstract

BACKGROUND: Renal dysfunction is an important prognostic factor in heart failure (HF), but whether this dysfunction progresses to end-stage renal disease (ESRD) is unknown. Therefore, we examined incidence and predictors of ESRD in outpatients with HF. METHODS AND
RESULTS: Patients with systolic HF were identified in The Danish Heart Failure database and new-onset ESRD from the Danish Registry on Dialysis. Renal function was estimated by The Chronic Kidney Disease Epidemiology Collaboration equation and patients grouped by estimated glomerular filtration rate (eGFR)-group I: ≥60 mL/min per 1.73 m(2), group II: 30 to 59 mL/min per 1.73 m(2), group III: 15 to 29 mL/min per 1.73 m(2), group IV: <15 mL/min per 1.73 m(2). Cox hazard models for time to ESRD, to death, and the composite end point of ESRD or death were constructed and predictors of ESRD identified. A total of 8204 patients were included in the analyses. Median age was 70 years (Q, 61-77), 28% were women, median left ventricular ejection fraction was 30% (Q, 24-40), and median eGFR was 68 (Q, 51-85) mL/min per 1.73 m(2). Forty-one patients developed ESRD (1.3/1000 patient-years). Baseline eGFR group II (P<0.001), eGFR group III (P<0.001), eGFR group IV (P<0.001), uncontrolled hypertension (P=0.049), need of diuretics, and age <60 years (P=0.016) were associated with time to ESRD.
CONCLUSIONS: ESRD is rare in outpatients with systolic HF and is mainly observed in patients with an eGFR <30 mL/min per 1.73 m(2). A low eGFR, age <60 years, need of diuretics, and uncontrolled hypertension identify patients with an increased risk for ESRD.

Entities:  

Keywords:  heart failure, systolic; kidney failure, chronic; proximal renal tubular dysfunction

Mesh:

Year:  2013        PMID: 24141097     DOI: 10.1161/CIRCHEARTFAILURE.113.000553

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  5 in total

1.  Beta-blockers in heart failure patients with severe chronic kidney disease-time for a randomized controlled trial?

Authors:  Rajiv Agarwal; Patrick Rossignol
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992

Review 2.  Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.

Authors:  Aaron M Hein; Julia J Scialla; Daniel Edmonston; Lauren B Cooper; Adam D DeVore; Robert J Mentz
Journal:  JACC Heart Fail       Date:  2019-05       Impact factor: 12.035

Review 3.  The Danish Nephrology Registry.

Authors:  James Heaf
Journal:  Clin Epidemiol       Date:  2016-10-25       Impact factor: 4.790

Review 4.  Renal dysfunction in cardiovascular diseases and its consequences.

Authors:  Giacomo Deferrari; Adriano Cipriani; Edoardo La Porta
Journal:  J Nephrol       Date:  2020-09-01       Impact factor: 3.902

Review 5.  Renal function monitoring in heart failure - what is the optimal frequency? A narrative review.

Authors:  Ahmed Al-Naher; David Wright; Mark Alexander John Devonald; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2017-10-22       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.